Enfusion Stock Forecast - Simple Regression

ENFN Stock  USD 10.02  0.11  1.09%   
The Simple Regression forecasted value of Enfusion on the next trading day is expected to be 9.90 with a mean absolute deviation of 0.27 and the sum of the absolute errors of 16.55. Enfusion Stock Forecast is based on your current time horizon. Although Enfusion's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Enfusion's systematic risk associated with finding meaningful patterns of Enfusion fundamentals over time.
  
At this time, Enfusion's Payables Turnover is very stable compared to the past year. As of the 29th of November 2024, Receivables Turnover is likely to grow to 6.88, while Inventory Turnover is likely to drop 6.17. . As of the 29th of November 2024, Common Stock Shares Outstanding is likely to drop to about 111.4 M. In addition to that, Net Loss is likely to drop to about (7.2 M).

Open Interest Against 2024-12-20 Enfusion Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Enfusion's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Enfusion's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Enfusion stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Enfusion's open interest, investors have to compare it to Enfusion's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Enfusion is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Enfusion. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Simple Regression model is a single variable regression model that attempts to put a straight line through Enfusion price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Enfusion Simple Regression Price Forecast For the 30th of November

Given 90 days horizon, the Simple Regression forecasted value of Enfusion on the next trading day is expected to be 9.90 with a mean absolute deviation of 0.27, mean absolute percentage error of 0.12, and the sum of the absolute errors of 16.55.
Please note that although there have been many attempts to predict Enfusion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enfusion's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Enfusion Stock Forecast Pattern

Backtest EnfusionEnfusion Price PredictionBuy or Sell Advice 

Enfusion Forecasted Value

In the context of forecasting Enfusion's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enfusion's downside and upside margins for the forecasting period are 7.89 and 11.90, respectively. We have considered Enfusion's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
10.02
9.90
Expected Value
11.90
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Enfusion stock data series using in forecasting. Note that when a statistical model is used to represent Enfusion stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.0038
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2713
MAPEMean absolute percentage error0.0298
SAESum of the absolute errors16.5498
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Enfusion historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Enfusion

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enfusion. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
7.9910.0212.05
Details
Intrinsic
Valuation
LowRealHigh
8.6410.6712.70
Details
Bollinger
Band Projection (param)
LowMiddleHigh
8.679.5610.44
Details
9 Analysts
Consensus
LowTargetHigh
9.2510.1711.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Enfusion. Your research has to be compared to or analyzed against Enfusion's peers to derive any actionable benefits. When done correctly, Enfusion's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Enfusion.

Other Forecasting Options for Enfusion

For every potential investor in Enfusion, whether a beginner or expert, Enfusion's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enfusion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enfusion. Basic forecasting techniques help filter out the noise by identifying Enfusion's price trends.

View Enfusion Related Equities

 Risk & Return  Correlation

Enfusion Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Enfusion's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Enfusion's current price.

Enfusion Market Strength Events

Market strength indicators help investors to evaluate how Enfusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enfusion shares will generate the highest return on investment. By undertsting and applying Enfusion stock market strength indicators, traders can identify Enfusion entry and exit signals to maximize returns.

Enfusion Risk Indicators

The analysis of Enfusion's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enfusion's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enfusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Enfusion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enfusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will appreciate offsetting losses from the drop in the long position's value.

Moving together with Enfusion Stock

  0.67U Unity Software Aggressive PushPairCorr
  0.71DJCO Daily Journal CorpPairCorr
  0.77AI C3 Ai Inc Earnings Call This WeekPairCorr
  0.81BL BlacklinePairCorr
  0.62DT Dynatrace Holdings LLCPairCorr

Moving against Enfusion Stock

  0.71VERB VERB TECHNOLOGY PANY Tech BoostPairCorr
  0.38EGAN eGainPairCorr
  0.34VTEX VTEXPairCorr
The ability to find closely correlated positions to Enfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enfusion to buy it.
The correlation of Enfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enfusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enfusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:
Check out Historical Fundamental Analysis of Enfusion to cross-verify your projections.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Earnings Share
0.04
Revenue Per Share
2.155
Quarterly Revenue Growth
0.154
Return On Assets
0.0592
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.